GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vicplas International Ltd (SGX:569) » Definitions » Gross Profit

Vicplas International (SGX:569) Gross Profit : S$58.7 Mil (TTM As of Jan. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Vicplas International Gross Profit?

Vicplas International's gross profit for the six months ended in Jan. 2024 was S$26.0 Mil. Vicplas International's gross profit for the trailing twelve months (TTM) ended in Jan. 2024 was S$58.7 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Vicplas International's gross profit for the six months ended in Jan. 2024 was S$26.0 Mil. Vicplas International's Revenue for the six months ended in Jan. 2024 was S$51.1 Mil. Therefore, Vicplas International's Gross Margin % for the quarter that ended in Jan. 2024 was 50.98%.

Vicplas International had a gross margin of 50.98% for the quarter that ended in Jan. 2024 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Vicplas International was 58.03%. The lowest was 51.51%. And the median was 54.87%.

Warning Sign:

Vicplas International Ltd gross margin has been in long-term decline. The average rate of decline per year is -1.4%.


Vicplas International Gross Profit Historical Data

The historical data trend for Vicplas International's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vicplas International Gross Profit Chart

Vicplas International Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 43.95 48.80 61.56 68.83 66.84

Vicplas International Semi-Annual Data
Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.74 35.09 34.22 32.62 26.03

Competitive Comparison of Vicplas International's Gross Profit

For the Medical Devices subindustry, Vicplas International's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vicplas International's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vicplas International's Gross Profit distribution charts can be found below:

* The bar in red indicates where Vicplas International's Gross Profit falls into.



Vicplas International Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Vicplas International's Gross Profit for the fiscal year that ended in Jul. 2023 is calculated as

Gross Profit (A: Jul. 2023 )=Revenue - Cost of Goods Sold
=129.216 - 62.377
=66.8

Vicplas International's Gross Profit for the quarter that ended in Jan. 2024 is calculated as

Gross Profit (Q: Jan. 2024 )=Revenue - Cost of Goods Sold
=51.057 - 25.027
=26.0

Gross Profit for the trailing twelve months (TTM) ended in Jan. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was S$58.7 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Vicplas International's Gross Margin % for the quarter that ended in Jan. 2024 is calculated as

Gross Margin % (Q: Jan. 2024 )=Gross Profit (Q: Jan. 2024 ) / Revenue (Q: Jan. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=26.0 / 51.057
=50.98 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Vicplas International  (SGX:569) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Vicplas International had a gross margin of 50.98% for the quarter that ended in Jan. 2024 => Durable competitive advantage


Vicplas International Gross Profit Related Terms

Thank you for viewing the detailed overview of Vicplas International's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Vicplas International (SGX:569) Business Description

Traded in Other Exchanges
N/A
Address
35 Joo Koon Circle, Singapore, SGP, 629110
Vicplas International Ltd is an investment holding company. The company is organized into two main business activities: the Pipes and Pipe Fitting segment and the Medical Devices segment, which is the key revenue driver. Pipes and Pipe Fittings segment engages in the manufacturing and distribution of plastic building products, including uPVC pipes and pipe fittings and electrical conduits. The Medical device segment is involved in the research, design, development, and manufacture of medical devices. The company generates majority of its revenue from medical devices. The company does its sales through geographical segments that include Singapore, Malaysia, China, and the United Kingdom, of which the majority of the revenue comes from Singapore.

Vicplas International (SGX:569) Headlines

No Headlines